The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.

Jeffrey M. Denney, University of Utah, Department of Obstetrics & Gynecology, Department of Maternal-Fetal Medicine, Salt Lake City, UT, USA Jennifer F. Culhane and Robert L. Goldenberg, Drexel ...

A level greater than 800 mcg/dL suggests a virilizing adrenal tumor. 17-hydroxyprogesterone (17OH-progesterone) is a useful screen for late-onset congenital adrenal hyperplasia (LOCAD).